This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga_article·Aug 18 at 07:45 AMBZ+5.51%SSMR-1.80%
Rani Therapeutics Expands Oral Biologics Push With Obesity, Immunology PipelineMarket Beat·Aug 16 at 03:01 PMRANI+1.37%CHGCY+0.14%
Canaccord Genuity Remains a Buy on Rani Therapeutics Holdings (RANI)Tip Ranks·Aug 13 at 07:45 AMRANI+1.37%
Rani Therapeutics to present at Canaccord Genuity Annual Growth ConferencePUBT·Aug 10 at 07:01 AMRANI+1.37%
Rani Therapeutics names Michelle Gilson to board as audit committee chairPUBT·Aug 4 at 07:01 AMRANI+1.37%GILD+1.38%
Rani Therapeutics director, 10% owner Mir A. Imran buys 36,000 shares worth $24,840PUBT·Jul 23 at 03:11 PMRANI+1.37%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 22 at 12:05 PMCPHI-8.00%PMI+86.16%
